1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. SYNDAX PHARMACEUTICALS INC
Syndax Pharmaceuticals Inc XNAS: SNDX

Syndax Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a ...

Read More
16.33 0.01 (0.06%)
27.42% Fall from 52W High
1.6M
XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Syndax Pharmaceuticals Inc is on 08 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment Conference See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
8.7 / 100
Momentum Score
Technically Neutral
59.8 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
36
1Yr Price target upside is 123%
11 analysts

14

S

13

W

4

O

1

T

SWOT Analysis

Syndax Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..